Cytokine signaling and APC activation lead to the cross-presentation of TAAs to T cells in lymph nodes, expansion of tumor-specific CD4+ and CD8+ T cells, and infiltration of cytotoxic T lymphocytes (CTLs) into the tumor [332,333]. The gene discussed is CD8A; the disease is neoplasm.